Topical Mometasone

@article{Prakash2012TopicalM,
  title={Topical Mometasone},
  author={Amitabh Prakash and Paul Benfield},
  journal={Drugs},
  year={2012},
  volume={55},
  pages={145-163}
}
SummarySynopsisMometasone, a synthetic 16α-methyl analogue of beclomethasone, is classified as a ‘potent’ glucocorticoid for dermatological use. It is available as 0.1% cream, ointment and lotion formulations for the treatment of patients with inflammatory glucocorticoid-responsive dermatoses.In patients with atopic dermatitis, the effects of mometasone 0.1% applied once daily over 2 to 3 weeks were similar to those of other glucocorticoids of similar potency, such as betamethasone dipropionate… Expand
Mometasone furoate 0.1 % ointment and hydrogel: a guide to their use in corticosteroid-responsive dermatoses
TLDR
In the treatment of moderate-to severe psoriasis, eczema and atopic dermatitis, the efficacy of mometasone furoate 0.1 % ointment applied once daily was greater than, or similar to, that of several other potent corticosteroids applied twice or three times daily. Expand
Efficacy, safety and tolerability of mometasone furoate 0.1% cream, ointment and lotion in childhood eczema
TLDR
Mometasone furoate 0.1% cream, ointment and lotion are found to be effective, safe and highly tolerable in childhood eczema and the compound was found equally safe in infants. Expand
An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
TLDR
Topical Tacrolimus 0.1% ointment could be better option for the treatment of localized vitiligo when compared to topical placental extract but in combination with a steroid cream. Expand
Mometasone Furoate
TLDR
Intranasal mometasone furoate improved the nasal symptoms of SAR and PAR to a significantly greater extent than placebo as determined by reductions from baseline in patient- and/or investigator-assessed total nasal symptom scores (TNSS). Expand
Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery
TLDR
SLNs proved the potential for topical delivery of corticosteroid drug over the conventional formulations and can be prepared, which would help in increasing skin deposition as well as provide sustained release. Expand
Efficacy of Elaeagnus angustifolia Topical Gel in the Treatment of Symptomatic Oral Lichen Planus
TLDR
The results suggest that 19% EA gel is efficient in the treatment of symptomatic oral lichen planus, with anti-inflammatory and analgesic effects, as well. Expand
Electrochemical investigations of mometasone furoate, a topical corticosteroid, in micellar medium
Abstract The electrochemical behavior of mometasone furoate (MF) has been studied at single-walled carbon nanotubes modified pyrolytic graphite electrode (MPG). Addition of cationic surfactantExpand
Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study
TLDR
It is demonstrated that the beneficial effect of SLIT with high or medium dose D. farinae Drops on AD, and the treatment was well tolerated, is demonstrated. Expand
Potential treatment of arthritis with an optimized Mometasone Furoate loaded-ethosomal gel in carrageenan-induced rat joint arthritis
Abstract The aim of this work was to improve the transdermal delivery of Mometasone Furoate (MF) by developing an optimal ethosomal system for targeting inflammatory cases. The effects ofExpand
Real‐world safety evaluation of topical corticosteroid use: A community pharmacy‐based, prospective, observational study
TLDR
The ADE incidence related to TCs was relatively low, and the real‐world safety of using TCs in the general population might not be greatly concerning, however, some populations who are highly at a risk of ADEs should be closely monitored and made aware regarding the risk. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 85 REFERENCES
Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
TLDR
Mometasone ointment and cream provide a highly effective once-a-day treatment for moderate to severe psoriasis with minimal risk of side effects. Expand
Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
TLDR
Mometasone furoate, a moderate- Potent steroid, produced significantly greater improvement than the low-potency hydrocortisone used twice daily, particularly evident in patients with involvement of more than 25% of their body surface area. Expand
Once-Daily 0.1% Mometasone Furoate Cream versus Twice-Daily 0.1% Betamethasone Valerate Cream in the Treatment of a Variety of Dermatoses
TLDR
It was concluded that mometasone furoate was as effective as betamethasone valerate in the treatment of a variety of steroid-responsive dermatoses, although momet asone f Kuroate was applied only half as frequently. Expand
SAFETY AND EFFICACY OF MOMETASONE FUROATE CREAM IN THE TREATMENT OF STEROID RESPONSIVE DERMATOSES
TLDR
While mometasone furoate is found to be a highly effective treatment for a variety of steroid‐responsive dermatoses, this drug has only a limited potential for production of local and systemic side effects, so a high margin of safety can be expected for patients using this drug. Expand
Mometasone furoate cream 0.1% vs. hydrocortisone cream 1% in the treatment of seborrhoeic dermatitis
The safety and efficacy of mometasone furoate cream 0.1% (applied once daily), and hydrocortisone cream 1% (applied twice. daily) were compared in a 6-week multicentre, randomized, third-party-blind,Expand
Mometasone furoate solution 0.1% compared with ketoconazole shampoo 2% for seborrheic dermatitis of the scalp
TLDR
This double-masked, randomized, parallel-group, comparative study of patients with moderate-to-severe seborrheic dermatitis of the scalp compared the efficacy of mometasone furoate solution once daily with ketoconazole shampoo 2% used twice a week to show time to onset of action for both agents. Expand
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
TLDR
Evidence of an increased benefit-risk ratio as compared to previous medium potent topical glucocorticoids is given, of particular interest facing psoriasis vulgaris where an antiproliferative activity of a drug is needed. Expand
Mometasone versus betamethasone creams: a trial in dermatoses.
TLDR
Mometasone furoate cream 0.1% applied daily in dermatoses is as effective as betamethasone valerate 0. Expand
Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
TLDR
MPA ointment has equal antiinflammatory activity and similar cortisol suppression but significantly fewer local side effects than mometasone furoate. Expand
Topical mometasone furoate and betamethasone‐17‐valerate decrease collagen synthesis to a similar extent in human skin in vivo
TLDR
It is concluded that MMF and BM‐17‐valerate decrease collagen synthesis to the same extent in human skin in vivo. Expand
...
1
2
3
4
5
...